Breaking News


A novel 200 mg itraconazole tablet for the treatment of onychomycosis


A randomized, multicenter, investigator-blinded, parallel-group, placebo-controlled study evaluated the efficacy and safety of itraconazole given as one 200-mg tablet q.d. versus itraconazole given as two 100-mg tablets q.d. for 12 weeks in 1,381 patients with onychomycosis. A 40-week follow-up was included. The superiority of the one itraconazole 200-mg tablet versus placebo was also assessed. The primary endpoint was complete cure of the great toenail at 52 weeks. Complete cure at week 52 was obtained in 22.3, 21.7 and 1% of the itraconazole 200 mg, itraconazole 2 x 100 mg and placebo groups, respectively. Superiority of the itraconazole 200-mg tablet to placebo (P < 0.001) was demonstrated and the itraconazole 200-mg tablet was ...

to Continue Reading, Login Now

Please Login

If you are a registered user but you have forgotten your password, please click here
If you are not a registered user, please register here

return to breaking news list